Guggenheim lowered the firm’s price target on Endava (DAVA) to $25 from $28 and keeps a Buy rating on the shares. While “mindful” of extended decision cycles as well as associated deal ramp timelines that may keep Endava in its admitted “air pocket” in its pursuit of larger core modernization deals, the risk/reward at current levels continues to skew positive, the analyst tells investors in a post-earnings note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava price target lowered to $17 from $33 at Morgan Stanley
- Endava Reports Strong Q3 FY2025 Financial Results
- Endava’s Hold Rating: Navigating Challenges Amidst Macroeconomic Volatility and Limited Recovery Prospects
- Endava downgraded to Hold from Buy at TD Cowen
- Endava: Balancing Challenges with Growth Opportunities Amid Fiscal Fluctuations
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue